Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayMay 01, 2025 10:51 am

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Appoints Mining Executive Peter Espig to Board as Montauban Project Nears Production 

ESGold (CSE: ESAU) (OTCQB: ESAUF) has appointed veteran mining executive and former global investment banker Peter Espig to its board of directors, as the company advances its fully permitted Montauban Gold-Silver Project in Quebec toward 2025 production. Espig brings decades of leadership across capital markets and mining operations, including a turnaround success as CEO of Nicola Mining. His appointment comes as ESGold focuses on production readiness, economic reassessment, 3D geological modeling and expanded exploration at Montauban.  To view the full press release, visit https://nnw.fm/V2MbQ  About ESGold Corp.  ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) is a fully permitted, pre-production resource company…

Continue Reading

ThursdayMay 01, 2025 10:24 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Granted FDA Waiver for $4.3 Million NDA Filing Fee for NRX-100

NRx Pharmaceuticals (NASDAQ: NRXP) announced it has received a $4.3 million New Drug Application filing fee waiver from the FDA for NRX-100, its preservative-free ketamine therapy for suicidal depression. The waiver, granted to small businesses and drugs deemed essential for public health, enables NRx to complete its NDA by the end of Q2 2025 using existing resources. NRX-100 offers a single-patient ketamine formulation without benzethonium chloride, a preservative associated with neurotoxicity. The company aims to secure FDA approval to provide insurance-covered treatment options beyond current off-label use.  To view the full press release, visit https://nnw.fm/9OQDW  About NRx Pharmaceuticals, Inc.  NRx…

Continue Reading

ThursdayMay 01, 2025 10:07 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Host Webinar on PC111 Antibody for Rare Skin Disorders 

Scinai Immunotherapeutics (NASDAQ: SCNI) will host a webinar May 7 at 11:30 a.m. EST to discuss the treatment potential of Pincell’s novel monoclonal antibody, PC111, for rare skin conditions Pemphigus Vulgaris and SJS/TEN. The session will cover unmet medical needs, PC111’s mechanism targeting soluble Fas ligand, and development plans. The event follows Scinai’s March agreement to acquire Pincell and a related €12 million grant application under Poland’s FENG program. Panelists include executives from Scinai and Pincell, with a live Q&A segment.  To view the full press release, visit https://nnw.fm/E19h6  About Scinai Immunotherapeutics Ltd.  Scinai is a biopharmaceutical company with two…

Continue Reading

ThursdayMay 01, 2025 9:50 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Appoints New CEO and President to Lead AI-Driven Hospitality Expansion

Nightfood Holdings (OTCQB: NGTF) has named Jimmy Chan as Chief Executive Officer and Ried Floco as President and Director, marking a major leadership transition aimed at accelerating the company’s growth in AI-powered hospitality automation and hotel operations. Chan brings capital markets and supply chain expertise, while Floco adds decades of hospitality leadership, including oversight of over 200 hotel properties. The appointments follow recent acquisitions of Skytech Automated Solutions and CarryOutSupplies.com, positioning Nightfood for vertically integrated expansion in the tech-enabled hospitality space. To view the full press release, visit https://nnw.fm/ptc86 About Nightfood Holdings Inc. Nightfood is a forward-thinking holding company dedicated to…

Continue Reading

ThursdayMay 01, 2025 9:20 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Aligns with Sustainable Football Investment Trends Highlighted by WSJ

Brera Holdings (NASDAQ: BREA) reaffirmed its commitment to a sustainable, community-focused multi-club ownership model, drawing parallels to trends highlighted in a recent Wall Street Journal article on the rise of U.S.-led football investments. The Company emphasized its strategic acquisition of Juve Stabia, now contending for Serie A promotion, as a prime example of its ladder-climbing approach. As the first publicly traded MCO group, Brera promotes long-term value creation by integrating local engagement, operational discipline, and public market transparency across its expanding global portfolio. To view the full press release, visit https://nnw.fm/V7VOt About Brera Holdings PLC Brera Holdings PLC is focused on…

Continue Reading

ThursdayMay 01, 2025 9:10 am

NetworkNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Successfully Road-Tests Thermoelectric Generator Radiator

First Tellurium (CSE: FTEL) (OTCQB: FSTTF) announced that its majority-owned subsidiary, PyroDelta Energy, has completed over 800 miles of successful road testing for its thermoelectric generator/radiator, which uses tellurium to convert waste heat into electricity. The device, which replaces both the alternator and radiator in combustion engine vehicles, features no moving parts, improves fuel efficiency, and can be installed without modifying vehicle designs. CEO Tyrone Docherty said the results exceeded expectations, and Head Engineer Michael Abdelmaseh highlighted its adaptability for both new and existing vehicles. The company also noted potential applications in data centers and EVs. A shareholder luncheon will be…

Continue Reading

ThursdayMay 01, 2025 9:00 am

NetworkNewsBreaks – Monogram Technologies Inc. (NASDAQ: MGRM) Secures Indian Regulatory Approval for Robotic Knee Surgery Clinical Trial  

Monogram Technologies (NASDAQ: MGRM), an AI-driven robotics company transforming orthopedic surgery, has received approval from India’s Central Drugs Standard Control Organization to import its mBôs TKA system and begin a 102-patient, multi-center clinical trial in partnership with Shalby Limited (NSE: SHALBY). The study will evaluate the safety and effectiveness of Monogram’s robotic total knee replacement system using a Consensus CKS implant and include three-month clinical follow-up across multiple Indian sites. Monogram will deploy full-time staff to support training and execution, with surgeries expected to begin within 90 business days. CEO Benjamin Sexson called the approval a major milestone toward commercial…

Continue Reading

WednesdayApr 30, 2025 3:39 pm

NetworkNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Engages IBN for Corporate Communications Expertise 

Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) is a junior resource company focused on monetizing high-grade mineral assets in British Columbia. The company leverages a unique dual-pronged operational strategy combining solid revenues from its wholly owned, state-of-the-art gold and silver mill with the long-term upside of 100%-owned copper, silver, and gold exploration projects. This approach allows the company to fund ongoing development while minimizing equity dilution.  Nicola Mining has selected IBN, a multifaceted financial news and publishing company serving private and public entities, to spearhead its corporate communications efforts. As part of the client-partner relationship, IBN will generate greater awareness for…

Continue Reading

WednesdayApr 30, 2025 12:16 pm

NetworkNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Closes First Tranche of Private Placement to Fund U.S. Marketing Push 

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a Swiss-hosted cybersecurity and privacy communications platform, has closed the first tranche of its non-brokered private placement, raising gross proceeds of CA$105,000. The company issued 3 million units at CA$0.035 each, with each unit consisting of one common share and one full warrant exercisable at CA$0.05 for 24 months. No finders' fees were paid. Sekur plans to use the proceeds to support U.S. marketing efforts for its privacy communications solutions and for general working capital.  To view the full press release, visit https://nnw.fm/kdTj7  About Sekur Private Data Ltd.  Sekur Private Data is…

Continue Reading

WednesdayApr 30, 2025 9:49 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting 2024 Milestones and 2025 Commercialization Goals 

Nutriband (NASDAQ: NTRB) has released a shareholder letter from CEO Gareth Sheridan outlining key achievements in 2024 and plans for 2025, centered on advancing its AVERSA™ abuse-deterrent transdermal technology. The company is transitioning from feasibility to commercial development of AVERSA Fentanyl in partnership with Kindeva Drug Delivery, targeting a pivotal Human Abuse Liability clinical trial and NDA filing. AVERSA Fentanyl and AVERSA Buprenorphine could reach peak annual sales of up to $200 million and $130 million respectively. Nutriband also expanded its global patent portfolio to 46 countries and raised $8.4 million in a non-brokered placement. The company expects continued revenue…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000